Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CNR2 antibody (AA 228-242)

This anti-CNR2 antibody is a Rabbit Polyclonal antibody detecting CNR2 in WB and IHC. Suitable for Rat.
Catalog No. ABIN7043025

Quick Overview for CNR2 antibody (AA 228-242) (ABIN7043025)

Target

See all CNR2 Antibodies
CNR2 (Cannabinoid Receptor 2 (CNR2))

Reactivity

  • 56
  • 27
  • 21
  • 2
  • 1
  • 1
Rat

Host

  • 59
  • 3
  • 1
Rabbit

Clonality

  • 60
  • 3
Polyclonal

Conjugate

  • 36
  • 5
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CNR2 antibody is un-conjugated

Application

  • 53
  • 32
  • 26
  • 23
  • 13
  • 13
  • 9
  • 8
  • 6
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)
  • Binding Specificity

    • 16
    • 12
    • 10
    • 5
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 228-242

    Purpose

    A Rabbit Polyclonal Antibody to Cannabinoid Receptor 2

    Specificity

    3rd intracellular loop

    Cross-Reactivity

    Mouse, Rat

    Predicted Reactivity

    Mouse - identical Human - 14 out of 15 amino acid residues identical

    Characteristics

    Anti-Cannabinoid Receptor 2 Antibody (ABIN7043025, ABIN7044157 and ABIN7044158) is directed against an intracellular epitope of the rat CB2 receptor. Anti-Cannabinoid Receptor 2 Antibody (ABIN7043025, ABIN7044157 and ABIN7044158) can be used in western blot and immunohistochemistry applications, and recognizes CB2 in rat samples.

    Purification

    Affinity purified on immobilized antigen.

    Immunogen

    Immunogen: Synthetic peptide

    Immunogen Sequence: (C)DRQVPGIARMRLDVR, corresponding to amino acid residues 228-242 of rat CB2 receptor

    Isotype

    IgG
  • Application Notes

    Antigen preadsorption control: 1 μg peptide per 1 μg antibody

    Application Dilutions Immunohistochemistry paraffin embedded sections ihc: 1:100-1:400

    Application Dilutions Western blot wb: 1:200

    Comment

    Cited Application: IHC

    Negative Control: (ABIN7235032)

    Blocking Peptide: (ABIN7235032)

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    0.2 mL double distilled water (DDW).

    Concentration

    1 mg/mL

    Buffer

    PBS pH 7.4

    Storage

    4 °C,-20 °C

    Storage Comment

    Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.

    Storage after reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).

  • Target

    CNR2 (Cannabinoid Receptor 2 (CNR2))

    Alternative Name

    CNR2

    Background

    CB2, CNR2,Cannabinoids have been used as pain relievers in Eastern medicine for many years.1 To date, two specific cannabinoid receptors have been identified: cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2).2 The cannabinoid receptors can be distinguished by their amino acid sequence, signaling mechanisms and tissue distribution.2 Both receptors belong to the G-protein coupled receptor superfamily and are coupled to Gi/0 G protein.2,3The CB2 receptor is highly expressed in cells of the immune system such as macrophages, lymphocytes natural killer cells and mast cells but has also been shown to be expressed, by both, in situ-hybridization and in immunohistochemistry, in spleen, thymus, and pancreas.1,2,4 CB2 expression in the brain is still much less characterized than that of CB1. Recently, it was demonstrated that CB2 is expressed in the brain and might have a role in controlling fundamental processes such as proliferation and survival of neural cells.5,6Overexpression of CB2 was reported in several cancers such as prostate, glioma and acute myeloid leukemias.6 In human astrocytoma a direct relationship between CB2 expression and tumor malignancy was demonstrated. Activation of CB2 in vivo by its agonist JWH-133, completely blocked cell growth. In C6 glioma, it was shown that activation of the CB2 by JWH-133 resulted in the internalization of only the CB2 and not CB1 leading to apoptosis of the cells. This may well be a new approach for the treatment of glioma.7

    Alternative names: Cannabinoid Receptor 2, CB2, CNR2

    Gene ID

    57302

    NCBI Accession

    NM_001841

    UniProt

    Q9QZN9
You are here:
Chat with us!